Patents by Inventor Yuji Fukamizu

Yuji Fukamizu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Azolylmethylidenehydrazine derivative and use thereof
    Patent number: 8022072
    Abstract: An azolylmethylidenehydrazine derivative represented by the formula (I) wherein Ar is an aryl group optionally having substituent(s) or a heteroaryl group optionally having substituent(s), R1 and R2 are the same or different and each is an alkyl group, a cycloalkyl group, an aralkyl group optionally having substituent(s), an aryl group optionally having substituent(s), a heteroarylalkyl group optionally having substituent(s), or R1 and R2 are bonded to each other to form a nitrogen-containing heterocyclic group optionally having substituent(s), and X is CH or a nitrogen atom, or a pharmacologically acceptable salt thereof is useful as a medicament, particularly as an antifungal agent, or an anti-inflammatory agent or an antiallergic agent.
    Type: Grant
    Filed: June 17, 2008
    Date of Patent: September 20, 2011
    Assignee: Kaken Pharmaceutical Co., Ltd.
    Inventors: Hironobu Ogura, Yoshiyuki Tatsumi, Yuji Fukamizu
  • AZOLYLMETHYLIDENEHYDRAZINE DERIVATIVE AND USE THEREOF
    Publication number: 20100190754
    Abstract: An azolylmethylidenehydrazine derivative represented by the formula (I) wherein Ar is an aryl group optionally having substituent(s) or a heteroaryl group optionally having substituent(s), R1 and R2 are the same or different and each is an alkyl group, a cycloalkyl group, an aralkyl group optionally having substituent(s), an aryl group optionally having substituent(s), a heteroarylalkyl group optionally having substituent(s), or R1 and R2 are bonded to each other to form a nitrogen-containing heterocyclic group optionally having substituent(s), and X is CH or a nitrogen atom, or a pharmacologically acceptable salt thereof is useful as a medicament, particularly as an antifungal agent, or an anti-inflammatory agent or an antiallergic agent.
    Type: Application
    Filed: June 17, 2008
    Publication date: July 29, 2010
    Applicant: KAKEN PHARMACEUTICAL CO., LTD.
    Inventors: Hironobu Ogura, Yoshiyuki Tatsumi, Yuji Fukamizu